Cocculus Ind
Over-the-Counterब्रांड नाम: COCCULUS IND
About This Medication
Oral preparation used for symptom management and health support.
सक्रिय तत्व
| घटक | शक्ति |
|---|---|
| Anamirta Cocculus Seed | - |
संकेत और उपयोग
खुराक और प्रशासन
चेतावनियाँ और सावधानियाँ
WARNINGS This product is to be used for self-limiting conditions If symptoms do not improve in 4 days, or worsen, discontinue use and seek assistance of health professional As with any drug, if you are pregnant, or nursing a baby, seek professional advice before taking this product Keep this and all medication out of reach of children Do not use if capseal is broken or missing. Close the cap tightly after use.
Frequently Asked Questions
INDICATIONS Condition listed above or as directed by the physician
DOSAGE Adults: Mix 4-6 drops in 1/2 cup of water, take orally three times daily or as directed by a physician. Children (2 years and older): Take half the adult dose.
WARNINGS This product is to be used for self-limiting conditions If symptoms do not improve in 4 days, or worsen, discontinue use and seek assistance of health professional As with any drug, if you are pregnant, or nursing a baby, seek professional advice before taking this product Keep this and all medication out of reach of children Do not use if capseal is broken or missing. Close the cap tightly after use.
Cocculus Ind is available over the counter (OTC) without a prescription.
Similar Tablet Products
Browse all Tablet products →References & Data Sources
- • DailyMed — Cocculus Ind drug label (National Library of Medicine)
- • openFDA — Cocculus Ind label data (U.S. Food & Drug Administration)
- • NDC Directory — Cocculus Ind (FDA National Drug Code)
चिकित्सा अस्वीकरण
इस पृष्ठ पर दी गई जानकारी केवल शैक्षणिक उद्देश्यों के लिए है और इसे पेशेवर चिकित्सा सलाह, निदान या उपचार के विकल्प के रूप में उपयोग नहीं किया जाना चाहिए।
किसी चिकित्सा स्थिति या दवा के बारे में आपके किसी भी प्रश्न के लिए हमेशा अपने चिकित्सक या अन्य योग्य स्वास्थ्य सेवा प्रदाता की सलाह लें।
डेटा स्रोत: DailyMed (NLM), openFDA, MFDS